First published · Last updated
Early adoption of lecanemab in Japan (December 2023–December 2024): Pretreatment diagnostic timelines from the DeSC claims database
Journal article reports on early adoption of lecanemab in Japan between December 2023 and December 2024, examining pretreatment diagnostic timelines using the DeSC claims database. The supplied excerpt contained only publication metadata and no further study details.
Categories: public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 4/10
- Global importance
- 3/10
- Impact magnitude
- 4/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The study concerns real-world adoption of a therapeutic agent in Japan and may inform health-sector stakeholders.

